Bard Associates’s NewAge, Inc. Common Stock (Delaware) NBEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-41,000
Closed -$213K 172
2018
Q4
$213K Sell
41,000
-4,000
-9% -$21K 0.12% 136
2018
Q3
$241K Sell
45,000
-20,000
-31% -$45.3K 0.11% 141
2018
Q2
$122K Sell
65,000
-3,000
-4% -$5.65K 0.06% 156
2018
Q1
$165K Hold
68,000
0.08% 148
2017
Q4
$148K Hold
68,000
0.07% 152
2017
Q3
$232K Hold
68,000
0.11% 149
2017
Q2
$349K Hold
68,000
0.16% 126
2017
Q1
$281K Buy
+68,000
New +$276K 0.13% 137

Other funds holding NBEV

Bard Associates's NBEV Position: Q1 2019 in Review

Bard Associates sold out of NewAge, Inc. Common Stock (Delaware) (NBEV) in Q1 2019, closing a stake of 41,000 shares — an estimated $213K sold.

Bard Associates first reported a position in NBEV in Q1 2017 and held it in 8 quarters. The position peaked at $349K in Q2 2017. 95 funds tracked by Wall St. Rank hold NBEV as of Q1 2019.

  • Bard Associates reported no remaining NewAge, Inc. Common Stock (Delaware) position as of Q1 2019 after selling out during the quarter.
  • Bard Associates sold 41,000 NewAge, Inc. Common Stock (Delaware) shares in Q1 2019, an estimated $213K.
  • Bard Associates first reported a position in NewAge, Inc. Common Stock (Delaware) in Q1 2017 and held it in 8 quarters.
  • Bard Associates's NewAge, Inc. Common Stock (Delaware) position peaked at $349K in Q2 2017.
  • 95 funds tracked by Wall St. Rank held NewAge, Inc. Common Stock (Delaware) as of Q1 2019.

Based on Bard Associates's 13F filing for Q1 2019, filed 13 May 2019.